Pneumonia, a critical pulmonary infection, can impact people of any stages. It arises when the air sacs in one or both lungs become inflamed and filled with mucus. This problem results in it challenging to respire and acquire enough air into the bloodstream. There are various kinds of pneumonia, spanning from slight cases to severe conditions, and

Ketoconazole has become a leading antifungal agent. This potent treatment effectively targets a wide range of fungal infections, making it a crucial tool in the fight against these unwelcome conditions. Its capacity to inhibit ergosterol biosynthesis, a essential component of fungal cell membranes, results in significant reduction of fungal growth.